25.9 C
Vientiane
Sunday, May 4, 2025
spot_img
Home Blog Page 546

Starburst Closes Record FY25, Fueled by Rising AI Demand and Growing Enterprise Momentum

BOSTON, Feb. 20, 2025 /PRNewswire/ — Starburst, the data platform for apps and AI, announced a record FY25 close, driven by strong demand from enterprise customers:

  • Grew net new customers by 20% and Starburst Galaxy customer growth by 76% year-over-year
  • Achieved record global sales, including significant growth in North America and EMEA
  • Increased adoption of Starburst Galaxy, its flagship cloud product, by 94% year-over-year
  • Signed the largest deal in the company’s history – a multi-year, eight-figure contract per year, with a global financial institution
  • Increased ARR per customer to over $325,000
  • Customers include 10 of the top 15 global banks
  • Selected by Dell Technologies to be the analytics query engine powering the Dell Data Lakehouse, the data platform for Dell’s AI Factory GTM

“Enterprises and governments worldwide have embraced our open, hybrid data lakehouse as a key enabler for their AI initiatives,” said Justin Borgman, Co-Founder and CEO of Starburst. “There is no AI without data. Starburst empowers organizations to secure, govern and provide compliant data access by the LLMs for RAG or agentic workflows – whether on-premises or in the cloud – unlocking AI-ready application development and deployment at scale.”

Customers around the world are partnering with Starburst to accelerate their AI journey.

“Starburst’s AI strategy reflects our deep partnership with customers,” said Steven Chung, President of Starburst. “These enterprises are aggressively driving AI adoption, and we’re excited to join them on this journey.”

About Starburst
Starburst is the data platform for analytics, applications, and AI, unifying data across clouds and on-premises to accelerate AI innovation. Organizations—from startups to Fortune 500 enterprises in 60+ countries around the globe — customers rely on Starburst for fast data access, seamless collaboration, and enterprise-grade governance on an open data lakehouse. Wherever data lives, Starburst unlocks its full potential, powering data and AI from development to deployment. By future-proofing data architecture, Starburst helps businesses fuel innovation with AI. Learn more at starburst.ai.

Media Contact:
Beth Winkowski, Public Relations for Starburst
beth@winkowskipr.com
978-649-7189

AEH Group and VitalEdge Technologies Partner to Implement the e-Emphasys Digital Transformation Platform

CARY, N.C., Feb. 20, 2025 /PRNewswire/ — VitalEdge Technologies, a global leader in enterprise software solutions for the heavy equipment and rental industries, is proud to announce that Agricultural Equipment Holdings (AEH Group), a leading provider of agricultural machinery and solutions in Australia, has selected VitalEdge as their digital transformation partner to enhance their operations and deliver superior customer experiences.

VitalEdge Technologies and Agricultural Equipment Holdings (AEH Group)
VitalEdge Technologies and Agricultural Equipment Holdings (AEH Group)

“We are excited to partner with VitalEdge Technologies as we embark on a transformative journey to enhance our operations and better serve our customers,” said David Thompson, Chief Operations Officer of AEH Group.” After a thorough evaluation of available solutions, we selected VitalEdge for their deep domain expertise, integrated cloud platform, advanced data analytics capabilities, commitment to innovation, and highly scalable platform. The e-Emphasys ERP solution and its suite of integrated applications will provide us with the tools and insights needed to streamline our processes, drive efficiency, and deliver even greater value to our clients. VitalEdge’s industry expertise and shared vision make them the ideal partner for this critical phase of our growth.”

As part of this strategic partnership, AEH Group will implement the e-Emphasys ERP solution and its integrated suite of applications across their entire organization. This deployment will include cutting-edge tools such as CRM for enhanced customer relationship management, Equipment Inspections for streamlined asset tracking, Mobile Field Service to empower technicians in the field, and Business Intelligence for actionable insights through advanced analytics. By adopting this comprehensive platform, AEH Group aims to optimize operational efficiency, enhance decision-making, and deliver superior service to their customers, positioning the company for long-term growth and success.

“We are thrilled to partner with AEH Group in their digital transformation journey,” said Vikram Savkar, CEO of VitalEdge Technologies. “By deploying our e-Emphasys ERP solution and integrated applications, AEH Group is not only streamlining its operations, but also laying the foundation for sustained growth and innovation. This partnership highlights the shared commitment of both organizations to harness cutting-edge technology to drive efficiency and deliver unparalleled value to customers in the agricultural and construction equipment industries. Australia and New Zealand are key areas of growth for VitalEdge, and this collaboration further strengthens our presence in the region. We have been highly impressed with AEH Group’s innovative business model and are excited to partner with them to help achieve their growth objectives.”

“We are confident that partnering with VitalEdge Technologies and implementing the e-Emphasys ERP solution will enable us to better serve our customers and enhance their overall experience,” said Patrick Joyce, National Service and Business Systems Manager of AEH Group. “This advanced technology will allow us to streamline our operations, provide real-time insights, and empower our team to deliver faster, more efficient service. By turning technology into a competitive advantage, we are not only strengthening our current capabilities but also building a technology foundation for sustained excellence in the years to come.”

About AEH Group

AEH Group operates 12 branches across Australia, providing farmers and contractors with top-tier agricultural and construction equipment solutions. As a leading provider in the industry, AEH Group offers an extensive range of machinery, including tractors, combine harvesters, and construction equipment, to meet the diverse needs of its customers. They proudly carry world-renowned brands such as New Holland Agriculture, known for innovative and efficient farming equipment, and New Holland Construction, offering durable machinery for construction and agricultural applications. Committed to supporting Australian agriculture, AEH Group combines cutting-edge technology with exceptional service across New South Wales, Victoria, and Tasmania. For more information, visit www.aehgroup.net.au.

About VitalEdge Technologies

VitalEdge Technologies is a leading global provider of dealer management solutions. Its e-Emphasys ERP and IntelliDealer DMS software suites give agriculture, construction, heavy truck, material handling, and other equipment dealers digital transformation and data intelligence technology to transform and grow their businesses. Designed to meet these clients’ industry-specific needs, its platforms connect every aspect of dealership operations and provide insights to increase efficiency, client satisfaction, and profitability. For more information, visit www.VitalEdge.com.

Photo – https://laotiantimes.com/wp-content/uploads/2025/02/vitaledge_technologies_and_agricultural_equipment_holdings_aeh_group.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2025/02/rgb_vitaledge_wordmark_logo.jpg

MicroCloud Hologram Inc. Develops Local Quantum Coherence (LQC) for Precise Detection of Quantum Phase Transition (QPT) Phenomena in Multi-Model Systems

SHENZHEN, China, Feb. 20, 2025 /PRNewswire/ — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, they focuses on the in-depth exploration of the connection between local quantum coherence (LQC) and quantum phase transition (QPT), providing new perspectives and theoretical foundations for understanding the characteristics and transition mechanisms of quantum systems.

The study of quantum phase transitions is of crucial importance for revealing the mysteries of quantum many-body systems, as well as for developing novel quantum materials and quantum devices. However, accurately detecting and understanding the process of quantum phase transitions has remained one of the key challenges in this field. HOLO introduces the important concept of local quantum coherence (LQC), based on Wigner-Yanase skew information, to study quantum phase transitions. Wigner-Yanase skew information is a significant quantity in quantum information theory, capable of characterizing the non-classical properties of quantum states. Local quantum coherence focuses on the quantum coherence properties in local regions of a quantum system. This coherence is one of the key distinguishing features between quantum and classical systems, reflecting the superposition property of quantum states and the degree of entanglement between quantum bits. In their research, HOLO applies LQC to several typical quantum models, including the one-dimensional Hubbard model with three-spin interactions, the XY spin chain model, and the Su-Schrieffer-Heeger model. The one-dimensional Hubbard model is an important model for describing the motion and interaction of electrons in a lattice and is widely used in condensed matter physics to study the properties of strongly correlated electron systems. The XY spin chain model mainly investigates the interactions between spins and the resulting quantum state properties. The Su-Schrieffer-Heeger model is commonly used to describe the electronic structure and superconducting phenomena in organic polymers.

Through in-depth studies of these models, HOLO discovered that LQC and its derivatives can successfully be used to detect different types of quantum phase transitions in spin and fermion systems. In these models, quantum phase transitions lead to significant changes in the system’s quantum states, and LQC is able to sensitively capture these changes. For example, in the one-dimensional Hubbard model, when the system undergoes a quantum phase transition from a metallic phase to an insulating phase, the value of LQC shows a clear discontinuity, which corresponds to the critical point of the quantum phase transition, providing a clear signal for determining the occurrence of the quantum phase transition. In the XY spin chain model, LQC can accurately reflect the changes in the correlation between spins during the quantum phase transition process, helping to deepen the understanding of the microscopic mechanisms behind quantum phase transitions.

Additionally, HOLO also investigated the role of LQC in detecting quantum phase transitions at finite temperatures. In real quantum systems, temperature often cannot be ignored, and finite temperatures can affect quantum states, potentially causing some quantum properties to vanish. In such cases, traditional tools used for detecting quantum phase transitions, such as entanglement, may lose their effectiveness. However, HOLO’s research shows that LQC, as a manifestation of quantum discord (QD), can still effectively detect quantum phase transitions at finite temperatures. Quantum discord is a broader measure of quantum correlations, which not only includes entanglement as a strong form of quantum correlation but also encompasses non-entangled yet quantum-correlated states. As a specific manifestation of quantum discord, LQC can capture subtle changes in quantum correlations within a system at finite temperatures, providing a new approach for detecting quantum phase transitions.

HOLO further demonstrated that, compared to quantum dots, LQC can exhibit different behaviors in various forms. Quantum dots are zero-dimensional quantum systems with unique quantum properties, commonly used in fields like quantum information processing and quantum computing. The behavior of LQC in quantum dot systems differs from that in other quantum systems, as it is influenced by factors such as the size, shape, and surrounding environment of the quantum dot. Through comparative studies, HOLO discovered that LQC displays a rich variety of characteristics in different quantum systems, providing important clues for further understanding the nature of quantum systems and for the development of novel quantum technologies.

HOLO’s research on the connection between LQC and QPT offers new theoretical tools and research methods for the study of quantum phase transitions. This achievement not only helps deepen our understanding of the fundamental properties of quantum many-body systems but also provides potential application directions for the design of future quantum materials and the development of quantum devices.

About MicroCloud Hologram Inc.

MicroCloud is committed to providing leading holographic technology services to its customers worldwide. MicroCloud’s holographic technology services include high-precision holographic light detection and ranging (“LiDAR”) solutions, based on holographic technology, exclusive holographic LiDAR point cloud algorithms architecture design, breakthrough technical holographic imaging solutions, holographic LiDAR sensor chip design and holographic vehicle intelligent vision technology to service customers that provide reliable holographic advanced driver assistance systems (“ADAS”). MicroCloud also provides holographic digital twin technology services for customers and has built a proprietary holographic digital twin technology resource library. MicroCloud’s holographic digital twin technology resource library captures shapes and objects in 3D holographic form by utilizing a combination of MicroCloud’s holographic digital twin software, digital content, spatial data-driven data science, holographic digital cloud algorithm, and holographic 3D capture technology. For more information, please visit http://ir.mcholo.com/

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s goals and strategies; the Company’s future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic; financial condition and results of operations; the expected growth of the holographic industry and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission (“SEC”), including the Company’s most recently filed Annual Report on Form 10-K and current report on Form 6-K and its subsequent filings. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Introducing Protelion: Your Trusted Cybersecurity Partner

BERLIN, Feb. 20, 2025 /PRNewswire/ — Protelion, a global cybersecurity company based in Berlin, Germany is focused on delivering advanced protection for government, critical infrastructures, law enforcement, and other multiple industries as well as private companies worldwide. Committed to innovation, Protelion develops cybersecurity solutions that adapt to today’s needs and future challenges. With an international team of experts, the company provides high-quality, user-friendly, and easily deployable products and services to secure the digital landscape.

Introducing Protelion
Protelion

Our Mission: We’re on a clear mission—to empower government organizations against cyber threats with secure, robust, and cost-effective solutions. We believe in progress through knowledge and lasting partnerships built on trust.

Our Approach: As your trusted cybersecurity partner, we offer a variety of reliable and secure products designed to meet all your needs. Our solutions, backed by proven technology, have been deployed globally, ensuring higher reliability and security in everyday operations.

Our Uniqueness: Your data security is our top priority. Protelion products feature highly secure encryption, meeting international standards. We also give you the choice of custom-specific algorithms for a personalized security approach.

Solutions  

When it comes to our different products, Protelion comes with a variety of choices. We provide innovative security solutions designed to protect government agencies and private infrastructures from cyber threat: We provide the following solutions:

  • VPN Data Protection which ensures secure data transfer.
  • Encrypted mobile communication that safeguards voice, calls, and messages, offering secure VoIP, chat, group-chat, text, and video features, along with data protection through a hardened phone.
  • Thread Detection and Response (TDR) which monitors and analyzes security threats in real-time.
  • Endpoint Protection, which is a comprehensive solution, designed to protect endpoints from various threats.

You can explore our products at Protelion webpage or reach out to us if you want to discuss how Protelion can enhance your organization’s cybersecurity.

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended 31 December 2024. All figures are in AU$ unless stated otherwise.

FY2024 highlights

  • Total revenue, driven primarily from sales of Illuccix® of $783.2 million, up by 56%1 from $502.5 million in 2023, beating full year guidance2.
  • Second year of profitable growth, delivered in a period of investment, including:
    • R&D investment of $194.6 million, in line with guidance, with a focus on late-stage assets.
    • Expanded global supply chain and product delivery infrastructure, including acquisitions of ARTMS, Inc. and IsoTherapeutics Group, LLC, and expansion of Telix Manufacturing Solutions’ Brussels South facility, resulting in an incremental increase of $15.8 million in manufacturing and distribution investment.
    • Adjusted EBITDA of $99.3 million, up by 70%, demonstrating strong underlying growth3.
  • Telix continued to deliver on its growth strategy. The Company’s key achievements, aligned to its strategic pillars:
    • Grow precision medicine: Prepared for launch of three new products TLX007-CDx (Gozellix®), TLX101-CDx (Pixclara®) and TLX250-CDx (Zircaix®)4 in 2025 while continuing to increase sales and market share for Illuccix®.
    • Deliver late-stage therapeutics: Expanded ProstACT GLOBAL Phase 3 prostate cancer therapy trial recruitment in the U.S. and continued to advance therapeutic trials for the brain and kidney cancer programs.
    • Build next generation pipeline: Delivered clinical proof-of-concept for first alpha therapy candidate in prostate cancer (TLX592) and added depth to urology franchise with acquisition of FAP5-targeting theranostic.
    • Expand global delivery infrastructure: Completed acquisitions of ARTMS, IsoTherapeutics and RLS (USA), Inc. (RLS)6 and expanded Brussels South facility, in preparation to commence GMP7 production in 2025.

For a full list of operational achievements, please refer to the Telix 2024 Annual Report

1.   All comparisons to Full Year 2023 results.

2.   Previously stated guidance of AU$745 million to AU$776 million (US$490 million to US$510 million).

3.   Adjusted EBITDA excludes one-off expenses related to both the Company’s U.S. capital markets activity ($9.1 million) and strategic acquisitions ($8.2 million).

4.   Launch and brand names subject to regulatory approval.

5.   Fibroblast activation protein. Transaction subject to customary closing conditions.

6.   RLS acquisition completed 27 January 2025, subsequent to year end. Refer to ASX disclosure.

7.   Good manufacturing practice.

 

Summary Group financial results

Full Year 2024

Full Year 2023

AU$M

AU$M

% change

Revenue

783.2

502.5

56 %

Cost of sales

(273.6)

(188.2)

45 %

Gross profit

509.6

314.3

62 %

Research and development (R&D)

(194.6)

(128.5)

51 %

Selling and marketing

(85.5)

(50.1)

71 %

Manufacturing and distribution

(25.7)

(9.9)

160 %

General and administration

(129.8)

(74.2)

75 %

Other gains/(losses) (net)

8.1

(35.9)

*

Operating profit

82.1

15.7

423 %

Profit after tax

49.9

5.2

860 %

Adjusted EBITDA1

99.3

58.4

70 %

Cash from operating activities

43.0

23.9

80 %

1. Earnings before interest, tax, depreciation and amortization.

Commentary

Group CEO, Dr. Christian Behrenbruch, commented on the result:

“2024 has been an extraordinary year for Telix. We generated strong financial growth while investing for the future. The Precision Medicine business is poised for step-change growth with three commercial product launches planned for this year in the U.S. and the European rollout of Illuccix. We have a deep therapeutic pipeline with multiple assets moving into pivotal trials, and we are building out the infrastructure to ensure we can deliver our products to patients around the world. We see 2025 as a year of significant growth and evolution for Telix in terms of international business, multiple product launches and the integration of key infrastructure that will further deliver on our mission to ensure global patient access.”

Further details on the Company’s results can be found in the Appendix 4E, investor presentation, and 2024 Annual Report lodged with the ASX and also available on the Company’s website.

Guidance

Telix provides FY2025 revenue guidance of $1.18 billion to $1.23 billion (US$770 million to US$800 million1). This guidance includes revenue from Illuccix (in jurisdictions with a marketing authorization)2 and 11 months of revenue from RLS (and excluding RLS revenue generated from Illuccix). Guidance does not reflect revenue for products that have not yet received a marketing authorization (for example, Gozellix, Pixclara and Zircaix3).

Telix has also provided R&D expenditure guidance, expecting an increased investment range of 20% to 25% compared to FY2024.

lnvestor call

An investor webcast will be held at 9.00am AEDT on Friday 21 February 2025 (5.00pm EST, Thursday 20 February 2025).

Participants can register for the webcast and find audio call details at the following link: https://s1.c-conf.com/ diamondpass/10044775-kmnuu.html

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. ARTMS, IsoTherapeutics, Lightpoint, Optimal Tracers and RLS are Telix Group companies. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

1.   Conversion to US$ is at an average exchange rate of AU$1 = US$0.65

2.   Does not include European countries for which national phase approval has not yet been granted.

3.   Launch and brand names subject to regulatory approval.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications Email: kyahn.williamson@telixpharma.com

Guidance Disclaimer

The stated revenue guidance is based on expected global and domestic economic conditions and is subject to known and unknown risks, uncertainties and other factors that may cause our actual results to differ materially. As such, investors are cautioned not to place undue reliance on this guidance and in particular Telix cannot guarantee a particular result. In compiling financial forecasts, a number of key variables that may have a significant impact on guidance have been identified and are listed below.

Key variables that could cause actual results to differ materially include: the success and timing of research and development activities; decisions by regulatory authorities regarding approval of our products as well as their decisions regarding label claims; competitive developments affecting our products; the ability to successfully market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pricing, reimbursement, access or tax; acquisitions and divestitures; research collaborations; litigation or government investigations; and Telix’s ability to protect its patents and other intellectual property.

This announcement has been authorized for release by the Telix Pharmaceuticals Limited Board of Directors

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Telix uses various non-IFRS information to reflect its underlying performance. For further information, the reconciliation of non-IFRS financial information to Telix’s statutory measures, reasons for usefulness and calculation methodology, please refer to the Alternative performance measures section in Telix’s Annual Report.

©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Telix Group company, and Telix product names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. Trademark registration status may vary from country to country.

Bybit FX Insight: Yen Carry Trade Outlook for 2025 and the Future of the Popular Funding Currency

DUBAI, UAE, Feb. 20, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, released a new FX Insight report examining the evolving landscape of the Japanese yen (JPY) carry trade, highlighting significant shifts that could reshape this fundamental trading strategy in 2025. The JPY has maintained its dominance as a funding currency in the FX markets, but this could be the year things start to change.

Figure 1: Japan Statistics Bureau, Bank of Japan (BoJ) and Ministry of Finance reports on inflation and wage growth trends.
Figure 1: Japan Statistics Bureau, Bank of Japan (BoJ) and Ministry of Finance reports on inflation and wage growth trends.

The report, titled “What to Look for in the Yen Carry Trade for 2025,” identifies several crucial developments that traders and investors should monitor:

  • The Japanese yen’s traditional role as a primary funding currency faces new scrutiny amid potential Bank of Japan (BoJ) policy shifts and evolving domestic economic conditions
  • Increased risk of rapid unwinding events due to possible yen strengthening, driven by BoJ monetary tightening or global risk-off scenarios
  • Emergence of alternative funding currencies, including the Swiss franc, euro, and U.S. dollar, reflecting the need for strategic diversification
  • Critical importance of adaptive risk management strategies in response to changing market dynamics

The analysis draws on comprehensive data from multiple authoritative sources, including the Bank of Japan, Federal Reserve, IMF, and Bloomberg Economics, providing traders with actionable insights for navigating this complex trading environment.

Japan’s economic landscape is shifting, with inflation finally breaching the BoJ’s long-standing 2% target, wage growth gaining momentum after years of stagnation, and increasing speculation about potential changes to the BoJ’s monetary policy framework,” the report said, which brings in questions about the yen’s future as a funding currency, “And whether we’re on the cusp of a resurgence in traditional carry trades or facing a structural shift that could redefine global FX strategies.” “In the emerging new era, FX market participants will need to adopt more dynamic strategies, emphasizing robust risk management and diversified approaches.”

The full report includes detailed historical context, current market analysis, and 2025 perspectives on alternative high-yielding currencies such as the Mexican Peso, South African Rand, and Turkish Lira.

To download the complete report and access Bybit’s latest market insights, visit Bybit Learn.

#Bybit / #TheCryptoArk /#BybitResearch

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

VALORANT Added to HERO ESPORTS Asian Champions League

SHANGHAI, Feb. 20, 2025 /PRNewswire/ — The HERO ESPORTS Asian Champions League (ACL), Asia’s premier multi-title esports tournament hosted by Hero Esports, has officially announced the addition of VALORANT to its inaugural lineup.


Previously, ACL unveiled six game titles: Dota 2, Counter-Strike 2 (CS2), Honor of Kings, Teamfight Tactics, Delta Force, and Crossfire. With VALORANT joining the roster, the total number of games now stands at seven, with more titles expected to be announced soon.

Through continued collaboration with the Esports World Cup, ACL has revealed that the champions of the ACL CS2 and Honor of Kings Tournaments will secure direct entry to the Esports World Cup. Further collaborations on the remaining titles of the ACL are anticipated.

The ACL VALORANT Tournament will be the only international-level VALORANT tournament held in China during the first half of 2025, attracting top teams from overseas. The Final of the event will take place offline in Shanghai. The event will use world-class production and cutting-edge live broadcasting technology to enhance audience experience.

The ACL is set to take place in the first half of 2025, with the Finals of the ACL CS2 Tournament and Honor of Kings Tournament scheduled for May. The ACL will have a total prize pool of $2 million.

Jonny Wang, CEO of the Asian Champions League, said: “We are excited to announce the addition of VALORANT to the ACL. Our ambition is to make ACL into a truly comprehensive tournament, providing a larger stage for players and teams across various competitions while delivering more exciting content for our audience.”

Danny Tang, Co-Founder and CEO of Hero Esports, said: “We are pleased by the progress of the ACL and its ability to attract top teams and titles to compete across Asia. We look forward to the continued collaboration between Hero Esports, ACL and the Esports World Cup Foundation, which is testament to our shared ambition to shape and empower esports globally.”

About Hero Esports

Founded in 2016, Hero Esports is the biggest esports company in Asia, producing more than 7,000 matches every year that captivate an online fan base of over 800 million. With a global presence encompassing 12 office locations and eight top-tier esports arenas, Hero Esports offers a comprehensive suite of esports services, including tournament organization, marketing solutions, community development, and more. As a private company, Hero Esports counts Savvy Games Group and Tencent, among others, as investors, with Kuaishou and Huya as strategic partners.

Headquartered in Shanghai and employing more than 1,100 employees, Hero Esports is a fully integrated operator of esports tournaments and creator of esports content with global reach. The company has helped produce many prestigious tournaments including the Olympic Esports Week, the Esports World Cup as well as the esports series featured at both the Jakarta Asian Games 2018 and the Hangzhou Asian Games 2023. Hero Esports also worked with the world’s top-tier game publishers such as Tencent and Krafton in organizing popular esports leagues such as the Honor of Kings’ KPL series and PUBG’s PGC series, among many others. In 2024, Hero Esports launched Esports Asian Champions League (ACL), Asia’s premier international, multi-title esports tournament. Hero Esports is a member of the Esports Integrity Commission (ESIC).

Innovative Surface Treatment in the Electronics Industry

STEINHAGEN, Germany, Feb. 20, 2025 /PRNewswire/ — Plasmatreat, a leading company in the field of surface treatment with plasma technology, developed the REDOX-Tool: an environmentally friendly, chemical-free solution for removing oxide layers from metal surfaces. This technology brings significant benefits to industries such as automotive, electronics and renewable energy.

Whether power modules, semiconductors or chips - oxide layers can be removed from metal electronic components in a matter of seconds by plasma treatment, thus supporting high-quality and durable end products. (Copyright Plasmatreat GmbH)
Whether power modules, semiconductors or chips – oxide layers can be removed from metal electronic components in a matter of seconds by plasma treatment, thus supporting high-quality and durable end products. (Copyright Plasmatreat GmbH)

The problem of oxide layers
Metal surfaces react when exposed to oxygen, forming unwanted oxide layers that can significantly affect the processing and functionality of components. Particularly in the electronics industry, where components are becoming smaller and more powerful, clean, oxide-free surfaces are essential to ensure the quality and lifetime of the product. Traditional methods for removing these layers are often based on aggressive chemicals and pollute the environment.

The solution: Plasmatreat’s REDOX-Tool
The new REDOX-Tool uses Openair-Plasma – a special form of plasma technology at atmospheric pressure – to clean surfaces precisely, efficiently and without the use of harmful chemicals. The process automatically removes oxide layers, allowing components to be processed immediately. This innovation can speed up production processes, reduce costs and protect the environment.

Easy integration and adaptation
The technology is not only environmentally friendly, but also extremely flexible: the REDOX-Tool can be easily integrated into existing production lines and adapted to different materials or requirements. Whether for the production of semiconductors, lead frames or power modules, the tool offers a solution for many applications and high volumes.

Highest efficiency with smallest components
“With the REDOX-Tool, we are setting new standards in the electronics industry. Even with the smallest components, we achieve outstanding results in oxide removal using environmentally friendly processes,” explains Nico Coenen, Global Director Electronics Market at Plasmatreat GmbH.

Eco-friendly, efficient and future-oriented
The REDOX-Tool combines top performance with sustainability and helps to meet the demands of modern industries. Plasmatreat thus underlines its status as a leading provider of innovative plasma technologies.

What is Openair-Plasma?
Plasma is also known as the 4th state of matter, alongside solids, liquids and gases. When energy is added to a gas, it becomes ionized and enters the energetic (ionized) plasma state. Whether it is plastic, metal, glass or paper, plasma technology is used to modify the properties of the surface to meet the requirements of the process. Subsequent processes include bonding, painting, printing or sealing.

Plasmatreat live at Semicon Korea, Seoul, booth 126 and at IPC Apex, Anaheim, CA, USA, booth 1600. Learn more at: www.plasmatreat.com

Comparison of copper plates treated in the REDOX-Tool (left) and oxidized copper plates (right). The difference between the copper plates without and with oxide layer is clearly visible. (Copyright: Plasmatreat GmbH)
Comparison of copper plates treated in the REDOX-Tool (left) and oxidized copper plates (right). The difference between the copper plates without and with oxide layer is clearly visible. (Copyright: Plasmatreat GmbH)